Abstract
The hypothesis was tested that sequence diversity in pregnane X receptor (PXR) cis-regulatory regions is a significant determinant of variation in inducible and constitutive CYP3A4 expression. A combination of comparative genomics and computational algorithms was used to select regions of the human PXR promoter and intron 1 that were resequenced in the polymorphism discovery resource 24 DNA subset. PXR single nucleotide polymorphisms (SNP) were then genotyped in donor human livers phenotyped for CYP3A4 and multidrug resistance protein 1 mRNA and primary human hepatocytes phenotyped for basal and rifampin-inducible CYP3A4 activity. The human PXR promoter [16.9 kilobase (kb)] was significantly larger than in rodents (2.9 kb). Eighty-nine SNPs were identified in the promoter and intron 1 of PXR. The SNPs most consistently associated with CYP3A4 phenotypic measures were a 44477T>C(-1359) promoter SNP (in linkage disequilibrium with SNP 463970, a 6-base pair deletion in intron 1a, and SNP 46551, a C nucleotide insertion in intron 1b); SNP 63396C>T in intron 1 (in linkage disequilibrium with SNP 63704A>G, a 63813(CAAA)(CA) variable repeat, and SNP 65104T>C); and SNP 56348C>A, SNP 69789A>G, and SNP 66034T>C. Donor livers with the variant PXR alleles had altered hepatic expression of PXR targets compared with livers with PXR wild-type alleles. These results identified PXR promoter and intron 1 SNPs associated with PXR target gene expression (CYP3A4) in donor livers and cultured hepatocytes and that a striking number of the linked intron 1 SNPs will affect putative binding sites for hepatic nuclear factor 3β (FOXA2), a transcription factor linked with PXR expression.
Footnotes
-
J.L. and V.L. contributed equally to this work.
-
This work is supported in part by the National Institutes of Health (NIH) Grant GM60346, NIH/National Institute of General Medical Sciences Pharmacogenetics Research Network and Database (U01GM61374, http://pharmgkb.org) under Grant U01 GM61393, and the NIH P30 CA21765 Cancer Center Support Grant, and by the American Lebanese Syrian Associated Charities (ALSAC).
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
-
doi:10.1124/dmd.107.016600.
-
ABBREVIATIONS: NR1I2/PXR, pregnane X receptor; PAR2, proteinase-activated receptor-2; MDR1, multidrug resistance protein 1; SNP, single nucleotide polymorphism; kb, kilobase; TF, transcription factor(s); HNF, hepatic nuclear factor; CEBP, CCAAT enhancer binding protein; NF, nuclear factor; ECR, evolutionary conserved region; PCR, polymerase chain reaction; bp, base pair; AAT1, testis-specific AMY-1 binding protein; GSK3B, glycogen synthase kinase-3β; STAT, signal transducer and activator of transcription; LD, linkage disequilibrium; IBD, inflammatory bowel disease.
- Received May 11, 2007.
- Accepted October 5, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|